ACAD
28.01
+0.16
+0.57%
AEMD
2.06
+0.01
+0.49%
APRI
1.04
+0.01
+0.97%
ARNA
1.34
+0.01
+0.75%
ATEC
2.09
+0.02
+0.97%
CNAT
5.3
+0.08
+1.53%
CRXM
0.121
-0.049
-28.824%
CYTX
0.96
-0.01
-1.03%
DXCM
68.85
+1.19
+1.76%
GNMK
13.21
+0.2
+1.54%
HALO
12.79
-0.12
-0.93%
ILMN
174.92
-2.09
-1.18%
INNV
0.108
+0.01
+9.6939%
INO
7.09
-0.08
-1.12%
ISCO
1.64
-0.09
-5.20%
ISIS
57.56
0.00
0.00%
LGND
113.44
-0.37
-0.33%
LPTN
2.93
0.00
0.00%
MBVX
1.71
-0.09
-5.00%
MEIP
1.64
+0.02
+1.23%
MNOV
5.65
+0.14
+2.54%
MRTX
3.65
0.00
0.00%
MSTX
0.131
0.00
0.00%
NBIX
53.64
+0.85
+1.61%
NUVA
71.54
+0.66
+0.93%
ONCS
0.9
-0.05
-5.14%
ONVO
2.81
+0.02
+0.72%
OREX
3.03
-0.12
-3.81%
OTIC
13.25
-0.15
-1.12%
QDEL
24.57
+0.16
+0.66%
RCPT
231.96
0.00
0.00%
RGLS
1.375
-0.075
-5.172%
RMD
69.51
+1.11
+1.62%
SCIE
0.001
0.00
0.00%
SPHS
2.48
-0.01
-0.40%
SRNE
1.725
+0.15
+9.524%
TROV
0.776
-0.025
-3.121%
VICL
2.29
+0.02
+0.88%
VOLC
18
0.00
0.00%
ZGNX
13.1
-0.25
-1.87%
ACAD
28.01
+0.16
+0.57%
AEMD
2.06
+0.01
+0.49%
APRI
1.04
+0.01
+0.97%
ARNA
1.34
+0.01
+0.75%
ATEC
2.09
+0.02
+0.97%
CNAT
5.3
+0.08
+1.53%
CRXM
0.121
-0.049
-28.824%
CYTX
0.96
-0.01
-1.03%
DXCM
68.85
+1.19
+1.76%
GNMK
13.21
+0.2
+1.54%
HALO
12.79
-0.12
-0.93%
ILMN
174.92
-2.09
-1.18%
INNV
0.108
+0.01
+9.6939%
INO
7.09
-0.08
-1.12%
ISCO
1.64
-0.09
-5.20%
ISIS
57.56
0.00
0.00%
LGND
113.44
-0.37
-0.33%
LPTN
2.93
0.00
0.00%
MBVX
1.71
-0.09
-5.00%
MEIP
1.64
+0.02
+1.23%
MNOV
5.65
+0.14
+2.54%
MRTX
3.65
0.00
0.00%
MSTX
0.131
0.00
0.00%
NBIX
53.64
+0.85
+1.61%
NUVA
71.54
+0.66
+0.93%
ONCS
0.9
-0.05
-5.14%
ONVO
2.81
+0.02
+0.72%
OREX
3.03
-0.12
-3.81%
OTIC
13.25
-0.15
-1.12%
QDEL
24.57
+0.16
+0.66%
RCPT
231.96
0.00
0.00%
RGLS
1.375
-0.075
-5.172%
RMD
69.51
+1.11
+1.62%
SCIE
0.001
0.00
0.00%
SPHS
2.48
-0.01
-0.40%
SRNE
1.725
+0.15
+9.524%
TROV
0.776
-0.025
-3.121%
VICL
2.29
+0.02
+0.88%
VOLC
18
0.00
0.00%
ZGNX
13.1
-0.25
-1.87%
Home » Archive by Category

Xconomy

ChromaCode Using $12M to Make Old-School PCR Tests More Powerful

May 4, 2017 – 6:35 am

The advent of high-throughput DNA sequencing has greatly accelerated biomedical research and discovery, and brought the cost of sequencing a whole human genome to roughly $1,000. But what if you…

[[Click headline to continue reading.]]

Cytori Reboots Azaya Facility After Buyout, Looks for European Deal

May 4, 2017 – 3:00 am

San Antonio — Cytori Therapeutics is in the process of restarting a San Antonio manufacturing facility it gained in February when it acquired Azaya Therapeutics, the maker of…

[[Click headline to continue reading.]]

If Budget Holds, NIH Precision Study Could Be Flush As Volunteers Arrive

May 4, 2017 – 2:30 am

Until this week, many U.S. government science agencies and programs seemed destined for a big haircut, plus the loss of a limb or two. That included the Precision Medicine Initiative, an ambitious…

[[Click headline to continue reading.]]

New San Diego Biotech Looks to Open Way for Anti-Cancer Drugs

May 3, 2017 – 4:00 am

In early 2002, the Finnish-born scientist Erkki Ruoslahti stepped down as CEO of what is now San Diego’s Sanford Burnham Prebys Medical Discovery Institute. He moved to Santa Barbara, CA, where he…

[[Click headline to continue reading.]]

CA Stem Cell Agency Chief Randy Mills to Leave After Three Years

May 2, 2017 – 11:58 am

[Updated 5/2/17, 7:30 p.m. ET. See below.] The head of California’s stem-cell agency is stepping down after three years on the job. C. Randall Mills, known as Randy, is leaving the agency to…

[[Click headline to continue reading.]]

Epic Sciences Advances Diagnostic for Late-Stage Prostate Cancer

April 30, 2017 – 8:44 pm

When San Diego’s Epic Sciences raised $30 million almost three years ago, CEO Murali Prahalad told me he saw a big opportunity to use the company’s technology as a diagnostic test to assess how well…

[[Click headline to continue reading.]]

Bio Roundup: Trumpcare Flails, Spinraza Sales, Batten OK & More

April 28, 2017 – 2:30 am

To judge the first 100 days of a new administration is, as many pundits have pointed out, an odd vestige of history, more convenient than significant. Which is why we’ll start this week’s…

[[Click headline to continue reading.]]

Gottlieb’s FDA Nomination Gets Committee Nod, Advances to Senate

April 27, 2017 – 7:53 am

Scott Gottlieb’s nomination to the top post of the FDA is on its way to the full U.S. Senate. The Senate Health, Education, Labor & Pensions Committee voted 14-9 on Thursday to approve Gottlieb’s…

[[Click headline to continue reading.]]

Will New Data Open “Bottlenecks” For Biogen’s Pricey Spine Drug?

April 26, 2017 – 9:30 am

Four months after its drug nusinersen (Spinraza) became the first ever approved to treat the rare genetic disease spinal muscular atrophy, Biogen (NASDAQ: BIIB) released study results Tuesday that…

[[Click headline to continue reading.]]

Forge Therapeutics Raises $15M to Take on Drug-Resistant Superbugs

April 25, 2017 – 11:06 am

One reason that drug-resistant “superbugs” are a growing healthcare problem is the hardiness of gram-negative bacteria, a type of bacteria whose characteristics render many antibiotics ineffective….

[[Click headline to continue reading.]]